These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

827 related articles for article (PubMed ID: 19059448)

  • 41. Incremental effect for antisocial personality disorder genetic risk combining 5-HTTLPR and 5-HTTVNTR polymorphisms.
    Garcia LF; Aluja A; Fibla J; Cuevas L; García O
    Psychiatry Res; 2010 May; 177(1-2):161-6. PubMed ID: 20363030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serotonin-1A receptor gene polymorphism and the ability of antipsychotic drugs to improve attention in schizophrenia.
    Sumiyoshi T; Tsunoda M; Higuchi Y; Itoh T; Seo T; Itoh H; Suzuki M; Kurachi M
    Adv Ther; 2010 May; 27(5):307-13. PubMed ID: 20533011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suicide ideators and attempters with schizophrenia--the role of 5-HTTLPR, rs25531, and 5-HTT VNTR Intron 2 variants.
    Božina N; Jovanović N; Podlesek A; Rojnić Kuzman M; Kudumija Slijepčević M; Roguljić A; Dimitrović A; Božina T; Lovrić J; Ljubić H; Medved V
    J Psychiatr Res; 2012 Jun; 46(6):767-73. PubMed ID: 22520017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of serotonin transporter gene polymorphism with obstructive sleep apnea syndrome.
    Ylmaz M; Bayazit YA; Ciftci TU; Erdal ME; Urhan M; Kokturk O; Kemaloglu YK; Inal E
    Laryngoscope; 2005 May; 115(5):832-6. PubMed ID: 15867649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia.
    Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Huang CH; Tsai GE
    J Clin Psychopharmacol; 2008 Feb; 28(1):64-8. PubMed ID: 18204343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subthreshold depression is linked to the functional polymorphism of the 5HT transporter gene.
    Gonda X; Juhasz G; Laszik A; Rihmer Z; Bagdy G
    J Affect Disord; 2005 Aug; 87(2-3):291-7. PubMed ID: 16002148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association study between glutathione S-transferase P1 polymorphism and schizophrenia in the Korean population.
    Pae CU; Kim JJ; Lee SJ; Lee CU; Lee C; Paik IH; Park HR; Yang S; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):519-23. PubMed ID: 12691788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Gene insertion and deletion polymorphism in the serotonin transporter gene and personality traits measured by MMPI].
    Golimbet VE; Alfimova MV; Shcherbatykh TV; Rogaev EI
    Genetika; 2003 Apr; 39(4):534-9. PubMed ID: 12760255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Serotonin transporter gene polymorphism in slow transit constipation].
    Ding JH; Fu CG; Zhao RH; Meng RG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jul; 9(4):328-30. PubMed ID: 16886116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].
    György B; Robert K; László C; Andrea J;
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gender-specific associations of depression with positive and negative symptoms in acute schizophrenia.
    Müller MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1095-100. PubMed ID: 17493732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between obsessive-compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene.
    Baca-Garcia E; Vaquero-Lorenzo C; Diaz-Hernandez M; Rodriguez-Salgado B; Dolengevich-Segal H; Arrojo-Romero M; Botillo-Martin C; Ceverino A; Piqueras JF; Perez-Rodriguez MM; Saiz-Ruiz J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):416-20. PubMed ID: 17174018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine.
    Reimherr F; Amsterdam J; Dunner D; Adler L; Zhang S; Williams D; Marchant B; Michelson D; Nierenberg A; Schatzberg A; Feldman P
    Psychiatry Res; 2010 Jan; 175(1-2):67-73. PubMed ID: 19969374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms.
    Kwon JS; Joo YH; Nam HJ; Lim M; Cho EY; Jung MH; Choi JS; Kim B; Kang DH; Oh S; Park T; Hong KS
    Arch Gen Psychiatry; 2009 Nov; 66(11):1233-41. PubMed ID: 19884611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of the serotonin transporter promotor polymorphism with suicide attempters with a high medical damage.
    Wasserman D; Geijer T; Sokolowski M; Frisch A; Michaelovsky E; Weizman A; Rozanov V; Wasserman J
    Eur Neuropsychopharmacol; 2007 Feb; 17(3):230-3. PubMed ID: 17029913
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression.
    Hranilovic D; Stefulj J; Schwab S; Borrmann-Hassenbach M; Albus M; Jernej B; Wildenauer D
    Biol Psychiatry; 2004 Jun; 55(11):1090-4. PubMed ID: 15158428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder.
    Ferreira Ade A; Neves FS; da Rocha FF; Silva GS; Romano-Silva MA; Miranda DM; De Marco L; Correa H
    J Affect Disord; 2009 Jan; 112(1-3):267-72. PubMed ID: 18534687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of an association between the COMT polymorphism and clinical symptomatology in schizophrenia.
    Strous RD; Lapidus R; Viglin D; Kotler M; Lachman HM
    Neurosci Lett; 2006 Jan; 393(2-3):170-3. PubMed ID: 16233957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the serotonin transporter in lymphocytes and platelets of schizophrenia patients treated with atypical or typical antipsychotics compared to healthy individuals.
    Barkan T; Peled A; Modai I; Weizman A; Rehavi M
    Eur Neuropsychopharmacol; 2006 Aug; 16(6):429-36. PubMed ID: 16431091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine.
    Zhao AL; Zhao JP; Zhang YH; Xue ZM; Chen JD; Chen XG
    Int J Neurosci; 2005 Nov; 115(11):1539-47. PubMed ID: 16223700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.